Azadeh Ebrahimzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Azadeh Ebrahimzadeh has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Zohreh Azarkar
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
5 shared publications - Gholamreza Sharifzadeh
Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
4 shared publications - Masood Ziaee
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
4 shared publications Bita Bijari
Hepatitis Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
2 shared publicationsGodratallah Naseh
Department of Surgery, Imam Reza Hospital, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications- Mahyar Mohammadifard
Department of Radiology, Imam Reza Hospital, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications
Latest Publications
- Open Access
- 1 September 2023
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 8  (3) , 96-101
The Role of Inflammatory Indices in Predicting Infections and Guiding Treatment in Neutropenic Patients With Solid Tumors
Introduction: This study explores the link between inflammatory markers and hospital outcomes in febrile neutropenic patients with solid cancers- a complication caused by systemic chemotherapy that can lead to hospitalization and requires timely diagnosis and treatment to reduce fatalities. Methods: This study was conducted in 2017 at Vali-e-Asr Hospital in Birjand with 22 participants. Blood samples were collected to measure inflammatory indexes. The study documented various hospital outcomes, including duration of neutropenia and fever correction, length of hospital stays, ICU admission or mechanical ventilation, and mortality. Accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each marker. Results: According to the findings, there was no significant difference in the mean duration of neutropenia, the duration of fever, or the length of hospital stay comparing procalcitonin (PCT; P=0.96, P=0.36, P=0.66, respectively), polymorphonuclears (PMNs; P=0.11, P=0.94, P=0.52, respectively), and erythrocyte sedimentation rate (ESR; P=0.41, P=0.24, P=0.17, respectively). Further, the performance metrics calculated for PCT, ESR, and PMNs were an accuracy of 50%, 50%, and 40.90%, sensitivity of 88.8%, 100%, and 88.8%, specificity of 23.07%, 15.38%, and 7.6%, PPV of 44.4%, 45%, and 40%, and NPV of 75%, 100%, and 50%, respectively. Conclusion: Our findings suggested that there was no significant relationship between inflammatory factors and hospital outcomes. However, further research is needed to explore the prognostic value of these markers in a larger and more diverse patient population.
- 1 September 2023
- Published by Maad Rayan Publishing Company in International Journal of Basic Science in Medicine
- Vol. 8  (3) , 96-101
Open AccessThe Role of Inflammatory Indices in Predicting Infections and Guiding Treatment in Neutropenic Patients With Solid Tumors
Introduction: This study explores the link between inflammatory markers and hospital outcomes in febrile neutropenic patients with solid cancers- a complication caused by systemic chemotherapy that can lead to hospitalization and requires timely diagnosis and treatment to reduce fatalities. Methods: This study was conducted in 2017 at Vali-e-Asr Hospital in Birjand with 22 participants. Blood samples were collected to measure inflammatory indexes. The study documented various hospital outcomes, including duration of neutropenia and fever correction, length of hospital stays, ICU admission or mechanical ventilation, and mortality. Accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each marker. Results: According to the findings, there was no significant difference in the mean duration of neutropenia, the duration of fever, or the length of hospital stay comparing procalcitonin (PCT; P=0.96, P=0.36, P=0.66, respectively), polymorphonuclears (PMNs; P=0.11, P=0.94, P=0.52, respectively), and erythrocyte sedimentation rate (ESR; P=0.41, P=0.24, P=0.17, respectively). Further, the performance metrics calculated for PCT, ESR, and PMNs were an accuracy of 50%, 50%, and 40.90%, sensitivity of 88.8%, 100%, and 88.8%, specificity of 23.07%, 15.38%, and 7.6%, PPV of 44.4%, 45%, and 40%, and NPV of 75%, 100%, and 50%, respectively. Conclusion: Our findings suggested that there was no significant relationship between inflammatory factors and hospital outcomes. However, further research is needed to explore the prognostic value of these markers in a larger and more diverse patient population.
- Open Access
- 14 December 2021
- Published by Brieflands in Modern Care Journal
- Vol. 18  (4)
Evaluating COVID-19 Knowledge, Attitudes, and Practice Among the Students of Birjand University of Medical Sciences: A Cross-sectional Survey
Background: With the onset of the coronavirus disease 2019 (COVID-19) pandemic in December 2019, healthcare systems faced an unprecedented challenge. Medical and paramedical students are the front-line warriors in this combat. Objectives: This study aimed to assess COVID-19 knowledge, attitudes, and practice among the students of Birjand University of Medical Sciences, Iran, in 2020. Methods: This cross-sectional analytical study was carried out on 329 students who passed the microbiology course from October 2020 to March 2021. The data collection tool was a researcher-made questionnaire consisting of four sections: demographic data, COVID-19-related knowledge, attitudes towards COVID-19, and participants’ practice. Finally, statistical analysis was performed in SPSS software version 19, and a significance level of 0.05 was considered in all tests. Results: A total of 329 medical, dentistry, pharmacy, and laboratory sciences students participated in this study. The mean score of COVID-19 knowledge was 10.26 ± 1.21 (out of 12). Among the participants, 103 (31.3%) individuals expressed being in crowded places in recent days, and 324 (98.5%) of them confirmed wearing masks. More than half of the students had positive attitudes towards COVID-19 control. The average knowledge was higher in females and medical and laboratory sciences students (P = 0.008). Also, the students' knowledge was inversely related to their practice of wearing a mask (P = 0.015). Conclusions: While students had a high level of COVID-19 knowledge, they had some misconceptions that should be included in educational programs. Students of medical sciences should be responsible for preventive behaviors and strive to be good role models for others.
- 14 December 2021
- Published by Brieflands in Modern Care Journal
- Vol. 18  (4)
Open AccessEvaluating COVID-19 Knowledge, Attitudes, and Practice Among the Students of Birjand University of Medical Sciences: A Cross-sectional Survey
Background: With the onset of the coronavirus disease 2019 (COVID-19) pandemic in December 2019, healthcare systems faced an unprecedented challenge. Medical and paramedical students are the front-line warriors in this combat. Objectives: This study aimed to assess COVID-19 knowledge, attitudes, and practice among the students of Birjand University of Medical Sciences, Iran, in 2020. Methods: This cross-sectional analytical study was carried out on 329 students who passed the microbiology course from October 2020 to March 2021. The data collection tool was a researcher-made questionnaire consisting of four sections: demographic data, COVID-19-related knowledge, attitudes towards COVID-19, and participants’ practice. Finally, statistical analysis was performed in SPSS software version 19, and a significance level of 0.05 was considered in all tests. Results: A total of 329 medical, dentistry, pharmacy, and laboratory sciences students participated in this study. The mean score of COVID-19 knowledge was 10.26 ± 1.21 (out of 12). Among the participants, 103 (31.3%) individuals expressed being in crowded places in recent days, and 324 (98.5%) of them confirmed wearing masks. More than half of the students had positive attitudes towards COVID-19 control. The average knowledge was higher in females and medical and laboratory sciences students (P = 0.008). Also, the students' knowledge was inversely related to their practice of wearing a mask (P = 0.015). Conclusions: While students had a high level of COVID-19 knowledge, they had some misconceptions that should be included in educational programs. Students of medical sciences should be responsible for preventive behaviors and strive to be good role models for others.
- Open Access
- 28 November 2021
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 77  (3) , 758-766
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
Background: The combination of sofosbuvir and daclatasvir has shown preliminary efficacy for hospitalized patients with COVID-19 in four open-label studies with small sample sizes. This larger trial aimed to assess if the addition of sofosbuvir/daclatasvir to standard care improved clinical outcomes in hospitalized patients with COVID-19. Methods: This was a placebo-controlled, double-blind, randomized clinical trial in adults hospitalized with COVID-19 at 19 hospitals in Iran. Patients were randomized to oral sofosbuvir/daclatasvir 400/60 mg once-daily or placebo in addition to standard of care. Patients were included if they had positive PCR or diagnostic chest CT, O2 saturation <95% and compatible symptoms. The primary outcome was hospital discharge within 10 days of randomization. Secondary outcomes included mortality and time to clinical events. The trial is registered on the Iran Registry of Clinical Trials under IRCT20200624047908N1. Results: Between July and October 2020, 1083 patients were randomized to either the sofosbuvir/daclatasvir arm (n = 541) or the placebo arm (n = 542). No significant difference was observed in the primary outcome of hospital discharge within 10 days, which was achieved by 415/541 (77%) in the sofosbuvir/daclatasvir arm and 411/542 (76%) in the placebo arm [risk ratio (RR) 1.01, 95% CI 0.95–1.08, P = 0.734]. In-hospital mortality was 60/541 (11%) in the sofosbuvir/daclatasvir arm versus 55/542 (10%) in the placebo arm (RR 1.09, 95% CI 0.77–1.54, P = 0.615). No differences were observed in time to hospital discharge or time to in-hospital mortality. Conclusions: We observed no significant effect of sofosbuvir/daclatasvir versus placebo on hospital discharge or survival in hospitalized COVID-19 patients.
- 28 November 2021
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 77  (3) , 758-766
Open AccessEvaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
Background: The combination of sofosbuvir and daclatasvir has shown preliminary efficacy for hospitalized patients with COVID-19 in four open-label studies with small sample sizes. This larger trial aimed to assess if the addition of sofosbuvir/daclatasvir to standard care improved clinical outcomes in hospitalized patients with COVID-19. Methods: This was a placebo-controlled, double-blind, randomized clinical trial in adults hospitalized with COVID-19 at 19 hospitals in Iran. Patients were randomized to oral sofosbuvir/daclatasvir 400/60 mg once-daily or placebo in addition to standard of care. Patients were included if they had positive PCR or diagnostic chest CT, O2 saturation <95% and compatible symptoms. The primary outcome was hospital discharge within 10 days of randomization. Secondary outcomes included mortality and time to clinical events. The trial is registered on the Iran Registry of Clinical Trials under IRCT20200624047908N1. Results: Between July and October 2020, 1083 patients were randomized to either the sofosbuvir/daclatasvir arm (n = 541) or the placebo arm (n = 542). No significant difference was observed in the primary outcome of hospital discharge within 10 days, which was achieved by 415/541 (77%) in the sofosbuvir/daclatasvir arm and 411/542 (76%) in the placebo arm [risk ratio (RR) 1.01, 95% CI 0.95–1.08, P = 0.734]. In-hospital mortality was 60/541 (11%) in the sofosbuvir/daclatasvir arm versus 55/542 (10%) in the placebo arm (RR 1.09, 95% CI 0.77–1.54, P = 0.615). No differences were observed in time to hospital discharge or time to in-hospital mortality. Conclusions: We observed no significant effect of sofosbuvir/daclatasvir versus placebo on hospital discharge or survival in hospitalized COVID-19 patients.
- Open Access
- 19 May 2021
- Published by Brieflands in Modern Care Journal
- Vol. 18  (1)
Comparison of Frequency Distribution of Diabetes in Hepatitis B and C Patients and Other People in Birjand
Background: Diabetes and hepatitis are among the most common diseases in the world. Hepatitis C virus leads to extra-liver manifestations, including endocrine disease and diabetes. The prevalence of hepatitis C and B in diabetic patients and the prevalence of diabetes in hepatitis C and B patients are higher than those in normal populations, and if each is added to the other, the complications will be more and the consequences will be worse. Objectives: This study aimed to compare the frequency distribution of diabetes and serum lipid levels in hepatitis B and C patients and other people. Methods: In this retrospective case-control study, 80 patients with hepatitis B and C and 160 patients without hepatitis were included. In both groups, those with two glucose levels above 126 mg/dL were considered as diabetic subjects. Also, the tests for factors such as cholesterol, TG, LDL, HbA1c, HDL, and liver ultrasonography were performed for patients. Data were collected and entered into SPSS 23 software and analyzed using descriptive statistical tests (t test and chi-square or Fisher's exact test) at a significance level of α = 0.05. Results: A total of 240 patients [80 cases (hepatitis B or C positive) and 160 controls] were enrolled. Of them, 46.3% were females and most of them were in the age range of 45-55 years. Besides, 14 (5.8%) subjects had high fasting blood glucose levels of more than 126 mg/dl twice, and were considered to have diabetes. Among them, four (5.0%) cases (all having hepatitis B) and 10 (6.3%) controls were diabetics. Statistical analysis showed no significant difference in the mean serum lipids of cholesterol and LDL between the case and control groups (P < 0.1) but there was a significant association between HDL and TG in both groups (P = 0.02). Conclusions: All patients with hepatitis B and C should be screened for diabetes, and in addition to fasting blood glucose, we suggest that HbA1c be measured to confirm or rule out diabetes.
- 19 May 2021
- Published by Brieflands in Modern Care Journal
- Vol. 18  (1)
Open AccessComparison of Frequency Distribution of Diabetes in Hepatitis B and C Patients and Other People in Birjand
Background: Diabetes and hepatitis are among the most common diseases in the world. Hepatitis C virus leads to extra-liver manifestations, including endocrine disease and diabetes. The prevalence of hepatitis C and B in diabetic patients and the prevalence of diabetes in hepatitis C and B patients are higher than those in normal populations, and if each is added to the other, the complications will be more and the consequences will be worse. Objectives: This study aimed to compare the frequency distribution of diabetes and serum lipid levels in hepatitis B and C patients and other people. Methods: In this retrospective case-control study, 80 patients with hepatitis B and C and 160 patients without hepatitis were included. In both groups, those with two glucose levels above 126 mg/dL were considered as diabetic subjects. Also, the tests for factors such as cholesterol, TG, LDL, HbA1c, HDL, and liver ultrasonography were performed for patients. Data were collected and entered into SPSS 23 software and analyzed using descriptive statistical tests (t test and chi-square or Fisher's exact test) at a significance level of α = 0.05. Results: A total of 240 patients [80 cases (hepatitis B or C positive) and 160 controls] were enrolled. Of them, 46.3% were females and most of them were in the age range of 45-55 years. Besides, 14 (5.8%) subjects had high fasting blood glucose levels of more than 126 mg/dl twice, and were considered to have diabetes. Among them, four (5.0%) cases (all having hepatitis B) and 10 (6.3%) controls were diabetics. Statistical analysis showed no significant difference in the mean serum lipids of cholesterol and LDL between the case and control groups (P < 0.1) but there was a significant association between HDL and TG in both groups (P = 0.02). Conclusions: All patients with hepatitis B and C should be screened for diabetes, and in addition to fasting blood glucose, we suggest that HbA1c be measured to confirm or rule out diabetes.
- Open Access
- 29 April 2020
- Published by Springer Nature in Research Square
Evaluation of ESBL (Extended Spectrum Beta-Lactamase) Producing Escherichia Coli Isolated from Patients with Urinary Tract Infection by Phenotypic and Genotypic Methods
Background: Urinary Tract Infection (UTI) is the most common bacterial infection in the world. E. coli is the predominant Pathogen. This study evaluates the prevalence of ESBL in E. colis isolated from patients with urinary tract infections with phenotypic and genotypic methods.Methods: This descriptive-analytical study was done on 155 isolates of E. coli isolated from patients with urinary tract infection who had received the study consent. After accurate identification of E. coli strains. ESBL production for Escherichia coli isolates which are resistant to ceftriaxone or ceftazidime was evaluated by CDT method. TEM, SHV and CTX-M genes were identified by PCR.Results: The results showed that 30 strains from 155 strains of E. coli had ESBL. Strains of ESBL producer were more in males was lower in educated persons. 38.9% of ESBL producer had antibiotic use, 29.9% -producing Escherichia hospitalization and 31.6% uti history. The highest level of drug allergy in the ESBL was related to nitrofurantoin, and the highest resistance was related to cefazolin, co-trimoxazole. The CTX-M and the CTX-M15 gene were found in 92.7% and 57.1% of cases, respectively; also the SHV and TEM genes were not found in any of ESBL-producing Escherichia coli strains. Most therapeutic response in patients was related to cefexime, ciprofloxacin and nitrofurantoin 27.4%, 26% 21.9%, respectively.Conclusion: This study showed that the history of antibiotic use, hospitalization, uti related to increase of ESBL-producing in E. coli isolates., the CTMX-M gene is the most common gene in ESBL-producing E. coli strains.
- 29 April 2020
- Published by Springer Nature in Research Square
Open AccessEvaluation of ESBL (Extended Spectrum Beta-Lactamase) Producing Escherichia Coli Isolated from Patients with Urinary Tract Infection by Phenotypic and Genotypic Methods
Background: Urinary Tract Infection (UTI) is the most common bacterial infection in the world. E. coli is the predominant Pathogen. This study evaluates the prevalence of ESBL in E. colis isolated from patients with urinary tract infections with phenotypic and genotypic methods.Methods: This descriptive-analytical study was done on 155 isolates of E. coli isolated from patients with urinary tract infection who had received the study consent. After accurate identification of E. coli strains. ESBL production for Escherichia coli isolates which are resistant to ceftriaxone or ceftazidime was evaluated by CDT method. TEM, SHV and CTX-M genes were identified by PCR.Results: The results showed that 30 strains from 155 strains of E. coli had ESBL. Strains of ESBL producer were more in males was lower in educated persons. 38.9% of ESBL producer had antibiotic use, 29.9% -producing Escherichia hospitalization and 31.6% uti history. The highest level of drug allergy in the ESBL was related to nitrofurantoin, and the highest resistance was related to cefazolin, co-trimoxazole. The CTX-M and the CTX-M15 gene were found in 92.7% and 57.1% of cases, respectively; also the SHV and TEM genes were not found in any of ESBL-producing Escherichia coli strains. Most therapeutic response in patients was related to cefexime, ciprofloxacin and nitrofurantoin 27.4%, 26% 21.9%, respectively.Conclusion: This study showed that the history of antibiotic use, hospitalization, uti related to increase of ESBL-producing in E. coli isolates., the CTMX-M gene is the most common gene in ESBL-producing E. coli strains.
- Open Access
- 8 April 2017
- Published by DoNotEdit in Iranian Red Crescent Medical Journal
- Vol. 20  (S1)
Seroprevalence and Risk Factors of Hepatitis E in Eastern Iran
Background: Hepatitis E infection is one of the most common causes of acute hepatitis. It is caused by the RNA virus of the hepatomegaly viridae family, which is transferred through stool in contaminated water. Cases of infection are most prevalent in developing countries. Objectives: This study was conducted to investigate the seroprevalence of hepatitis E among urban adults. The reason was the current lack of information on the hepatitis E prevalence among the general population in the city of Birjand in eastern Iran. This information is necessary because Southern Khorasan is in close proximity to Afghanistan. Methods: In this cross sectional study, 522 participants aged over 17 years were selected from the city of Birjand, eastern Iran, using the random cluster sampling. The participants completed a researcher-made questionnaire that included demographic characteristics, risk factors for infectious diseases such as records of blood transfusions, specific exposures, intravenous drug abuse, recent diagnosis or a history of liver disease, and other medical information. After selection, a blood sample was taken from each participant to a volume of 5 cc. Each blood sample was then measured for the title of IgG antivirus of hepatitis E by the enzyme-linked immunosorbent assay (ELISA) method using the third generation ELISA kit made by Delavara Company. Results: This study included 554 participants. The mean age of the participants was 41.4 ± 14.3 years (age range, 17 - 72 years). From a total of 554 participants, 295 (53.2%) were females and the remainder were males. Results showed that the hepatitis E antibody title was positive in 139 (25.1%) participants and negative in the others. Comparison of the prevalence rates of positive HEV between men and women showed no statistically significant difference although it was significantly higher in married participants than in single ones (P < 0.001). Results also showed that the prevalence was less in participants with a tertiary education compared to those with a lower level education. Along with age, the prevalence of the positive antibody title increased significantly. The prevalence of HEV in participants who were smokers was significantly (P < 0.001) lower than in those who were nonsmokers. Conclusions: In this study, the seroprevalence of contact with HEV in urban adults in the city of Birjand was 25%. The results of this study showed that the prevalence of hepatitis E in the city of Birjand, eastern Iran, was higher than in other places compared with previous studies on communities in Iran. Also, the prevalence of HEV in single and educated people was significantly less than that in married and literate individuals. Keywords: Prevalence; Risk Factors; Hepatitis E; Eastern Iran
- 8 April 2017
- Published by DoNotEdit in Iranian Red Crescent Medical Journal
- Vol. 20  (S1)
Open AccessSeroprevalence and Risk Factors of Hepatitis E in Eastern Iran
Background: Hepatitis E infection is one of the most common causes of acute hepatitis. It is caused by the RNA virus of the hepatomegaly viridae family, which is transferred through stool in contaminated water. Cases of infection are most prevalent in developing countries. Objectives: This study was conducted to investigate the seroprevalence of hepatitis E among urban adults. The reason was the current lack of information on the hepatitis E prevalence among the general population in the city of Birjand in eastern Iran. This information is necessary because Southern Khorasan is in close proximity to Afghanistan. Methods: In this cross sectional study, 522 participants aged over 17 years were selected from the city of Birjand, eastern Iran, using the random cluster sampling. The participants completed a researcher-made questionnaire that included demographic characteristics, risk factors for infectious diseases such as records of blood transfusions, specific exposures, intravenous drug abuse, recent diagnosis or a history of liver disease, and other medical information. After selection, a blood sample was taken from each participant to a volume of 5 cc. Each blood sample was then measured for the title of IgG antivirus of hepatitis E by the enzyme-linked immunosorbent assay (ELISA) method using the third generation ELISA kit made by Delavara Company. Results: This study included 554 participants. The mean age of the participants was 41.4 ± 14.3 years (age range, 17 - 72 years). From a total of 554 participants, 295 (53.2%) were females and the remainder were males. Results showed that the hepatitis E antibody title was positive in 139 (25.1%) participants and negative in the others. Comparison of the prevalence rates of positive HEV between men and women showed no statistically significant difference although it was significantly higher in married participants than in single ones (P < 0.001). Results also showed that the prevalence was less in participants with a tertiary education compared to those with a lower level education. Along with age, the prevalence of the positive antibody title increased significantly. The prevalence of HEV in participants who were smokers was significantly (P < 0.001) lower than in those who were nonsmokers. Conclusions: In this study, the seroprevalence of contact with HEV in urban adults in the city of Birjand was 25%. The results of this study showed that the prevalence of hepatitis E in the city of Birjand, eastern Iran, was higher than in other places compared with previous studies on communities in Iran. Also, the prevalence of HEV in single and educated people was significantly less than that in married and literate individuals. Keywords: Prevalence; Risk Factors; Hepatitis E; Eastern Iran
- Open Access
- 14 August 2016
- Published by Brieflands in Hepatitis Monthly
- Vol. 16  (9) , e36452
Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran
Background: Infection with the hepatitis B virus (HBV) is an important global health problem. Knowledge of the geographic distribution pattern of HBV infection can help to control the spread of the disease. Objectives: To determine the prevalence of HBV infections and risk factors for the disease for the first time in Birjand, Southeastern Iran. Methods: This was an analytical cross-sectional study conducted in 2013 - 2014 of 5235 HBV cases in Birjand, South Khorasan Iran. Subjects aged 15 - 70 y were selected using the cluster sampling method. Blood samples were taken and tested at a reference laboratory for the hepatitis B core antibody (anti-HBc). Seropositive specimens were tested for the hepatitis B surface antigen (HBsAg). Results: The mean age (± SD) was 39.07 (± 14.04) y, and 786 (15%) subjects were anti-HBc positive. The prevalence of HBsAg was 1.6% (n = 85). The prevalence of anti-HBc seropositivity was significantly higher in subjects with a lower level of education (P = 0.09), older subjects (P = 0.001), intravenous (IV) drug users (P<0.05), subjects with piercings (P < 0.001), and subjects with a positive history of familial HBV or HCV infection (P < 0.05). It was also significantly higher in those who drank alcohol (P = 0.09) or had a history of blood transfusions (P = 0.001), cupping (P = 0.004), hospital admission (P = 0.03), or endoscopy (P = 0.002). The rate of HBsAg positivity was significantly higher in subjects with a history of cupping (P=0.03), a positive history of familial HBV or HCV infection (P < 0.05), and older subjects (P = 0.015). Conclusions: Although the frequency of HBsAg seropositivity in the present study was close to that observed in the overall Iranian population, the seroprevalence of anti-HBc was higher, possibly due to the exposure of the elderly to more risk factors. The risk factors were similar. These included a history of blood transfusions, cupping, hospital admission, endoscopy, or familial HBV/HCV infection, in addition to piercings and drug abuse. Keywords: Hepatitis B; Epidemiology; Risk Factor, Iran; Hepatitis B Surface Antigen
- 14 August 2016
- Published by Brieflands in Hepatitis Monthly
- Vol. 16  (9) , e36452
Open AccessSeroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran
Background: Infection with the hepatitis B virus (HBV) is an important global health problem. Knowledge of the geographic distribution pattern of HBV infection can help to control the spread of the disease. Objectives: To determine the prevalence of HBV infections and risk factors for the disease for the first time in Birjand, Southeastern Iran. Methods: This was an analytical cross-sectional study conducted in 2013 - 2014 of 5235 HBV cases in Birjand, South Khorasan Iran. Subjects aged 15 - 70 y were selected using the cluster sampling method. Blood samples were taken and tested at a reference laboratory for the hepatitis B core antibody (anti-HBc). Seropositive specimens were tested for the hepatitis B surface antigen (HBsAg). Results: The mean age (± SD) was 39.07 (± 14.04) y, and 786 (15%) subjects were anti-HBc positive. The prevalence of HBsAg was 1.6% (n = 85). The prevalence of anti-HBc seropositivity was significantly higher in subjects with a lower level of education (P = 0.09), older subjects (P = 0.001), intravenous (IV) drug users (P<0.05), subjects with piercings (P < 0.001), and subjects with a positive history of familial HBV or HCV infection (P < 0.05). It was also significantly higher in those who drank alcohol (P = 0.09) or had a history of blood transfusions (P = 0.001), cupping (P = 0.004), hospital admission (P = 0.03), or endoscopy (P = 0.002). The rate of HBsAg positivity was significantly higher in subjects with a history of cupping (P=0.03), a positive history of familial HBV or HCV infection (P < 0.05), and older subjects (P = 0.015). Conclusions: Although the frequency of HBsAg seropositivity in the present study was close to that observed in the overall Iranian population, the seroprevalence of anti-HBc was higher, possibly due to the exposure of the elderly to more risk factors. The risk factors were similar. These included a history of blood transfusions, cupping, hospital admission, endoscopy, or familial HBV/HCV infection, in addition to piercings and drug abuse. Keywords: Hepatitis B; Epidemiology; Risk Factor, Iran; Hepatitis B Surface Antigen
- Open Access
- 23 January 2016
- Published by Brieflands in International Journal of Infection
- Vol. 3  (1)
Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014
Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014 - International Journal of Infection - - Zahedan University of Medical Sciences
- 23 January 2016
- Published by Brieflands in International Journal of Infection
- Vol. 3  (1)
Open AccessPrevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014
Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014 - International Journal of Infection - - Zahedan University of Medical Sciences
- Open Access
- 1 January 2016
- Vol. 41  (1) , 44-47
Time to Sputum Smear Conversion in Smear-Positive Pulmonary Tuberculosis Patients and Factors for Delayed Conversion
Pulmonary tuberculosis is a common infection worldwide. In the eastern part of Iran, fluctuations in tuberculosis prevalence are seen due to the migration of people from Afghanistan. The aim of this study was to evaluate the time of bacteriologic sputum conversion after treatment and affecting factors in those whose smear does not become negative. This study was carried out on 85 smear-positive pulmonary tuberculosis patients with the mean age of 65.6±16.7 years. There were 38 male patients (44.7%), 47 urban residents (55.3%), and only 6 patients (7.1%) from Afghanistan. The mean time of sputum conversion after starting treatment was 1.99±1.06 months. The mean time of sputum conversion was significantly higher in males (P=0.046), increased bacilli density in the primary sputum sample (P<0.0001, R=0.507), and pre-existing medical illness (P=0.001). In this study, it was revealed that pre-existing illness, bacilli density in initial smear, and severe involvement of the lung on radiography, could be associated with delay in sputum smear conversion.
- 1 January 2016
- Vol. 41  (1) , 44-47
Open AccessTime to Sputum Smear Conversion in Smear-Positive Pulmonary Tuberculosis Patients and Factors for Delayed Conversion
Pulmonary tuberculosis is a common infection worldwide. In the eastern part of Iran, fluctuations in tuberculosis prevalence are seen due to the migration of people from Afghanistan. The aim of this study was to evaluate the time of bacteriologic sputum conversion after treatment and affecting factors in those whose smear does not become negative. This study was carried out on 85 smear-positive pulmonary tuberculosis patients with the mean age of 65.6±16.7 years. There were 38 male patients (44.7%), 47 urban residents (55.3%), and only 6 patients (7.1%) from Afghanistan. The mean time of sputum conversion after starting treatment was 1.99±1.06 months. The mean time of sputum conversion was significantly higher in males (P=0.046), increased bacilli density in the primary sputum sample (P<0.0001, R=0.507), and pre-existing medical illness (P=0.001). In this study, it was revealed that pre-existing illness, bacilli density in initial smear, and severe involvement of the lung on radiography, could be associated with delay in sputum smear conversion.
- Open Access
- 1 March 2015
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 4, 148
Radiologic findings in patients with smear-negative pulmonary tuberculosis
Aim and objectiveTuberculosis (TB) is a chronic lung infection that contaminated 1/3 of the people in the world and that causes 2 million deaths and 9 million infected with the disease. Sputum smear and Ziehl-Neelsen staining are the best methods for diagnosis of TB, but chest X-ray is another method that can help diagnose pulmonary TB, and it is especially helpful for smear-negative patients. The aim of this study is to show that radiologic findings can assist in diagnoses in pulmonary TB smear-negative groups.MethodsIn this descriptive analytical study, 100 patients with smear-negative pulmonary TB during the time period 2010–2011 were enrolled. The standard World Health Organization (WHO) definition of smear-negative was used in this study. All patients had a chest X-ray (PA and lateral).Data were analyzed with cisquire and T test with the use of SPSS and P<0.05 was significant.ResultsOf the 100 patients, 63.5% were female and 97% Iranian; 25% of patients had ESR more than 50 frequency. Calcification, Hilar adenopathy, incomplete pulmonary destruction and bronchiectasis was 27%, 21%, 14% and 11%, respectively, but frequent reticulonodular infiltration and pulmonary fibrosis (41% and 23%, respectively) were not significant (P=0.2).ConclusionRadiologic findings for pulmonary TB cannot be used to diagnose, but are rather suggestive
- 1 March 2015
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 4, 148
Open AccessRadiologic findings in patients with smear-negative pulmonary tuberculosis
Aim and objectiveTuberculosis (TB) is a chronic lung infection that contaminated 1/3 of the people in the world and that causes 2 million deaths and 9 million infected with the disease. Sputum smear and Ziehl-Neelsen staining are the best methods for diagnosis of TB, but chest X-ray is another method that can help diagnose pulmonary TB, and it is especially helpful for smear-negative patients. The aim of this study is to show that radiologic findings can assist in diagnoses in pulmonary TB smear-negative groups.MethodsIn this descriptive analytical study, 100 patients with smear-negative pulmonary TB during the time period 2010–2011 were enrolled. The standard World Health Organization (WHO) definition of smear-negative was used in this study. All patients had a chest X-ray (PA and lateral).Data were analyzed with cisquire and T test with the use of SPSS and P<0.05 was significant.ResultsOf the 100 patients, 63.5% were female and 97% Iranian; 25% of patients had ESR more than 50 frequency. Calcification, Hilar adenopathy, incomplete pulmonary destruction and bronchiectasis was 27%, 21%, 14% and 11%, respectively, but frequent reticulonodular infiltration and pulmonary fibrosis (41% and 23%, respectively) were not significant (P=0.2).ConclusionRadiologic findings for pulmonary TB cannot be used to diagnose, but are rather suggestive